SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-23-025645
Filing Date
2023-07-27
Accepted
2023-07-27 12:16:22
Documents
22

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 4060176
2 ex15-1.htm EX-15.1 6449
3 ex23-1.htm EX-23.1 5861
4 ex99-10.htm EX-99.10 4302
5 ex99-11.htm EX-99.11 4160
6 ex99-12.htm EX-99.12 4192
7 formdrs_001.jpg GRAPHIC 6403
8 formdrs_002.jpg GRAPHIC 6881
9 formdrsa_021.jpg GRAPHIC 68475
10 formdrs_004.jpg GRAPHIC 43006
11 formdrs_005.jpg GRAPHIC 47484
12 formdrs_007.jpg GRAPHIC 83370
13 formdrsa_022.jpg GRAPHIC 68475
14 formdrs_010.jpg GRAPHIC 137512
15 audit_001.jpg GRAPHIC 9522
16 audit_002.jpg GRAPHIC 8358
17 audit_003.jpg GRAPHIC 11327
18 audit_004.jpg GRAPHIC 6322
19 finapril_001.jpg GRAPHIC 69761
20 ex15_001.jpg GRAPHIC 13169
21 ex23-1_001.jpg GRAPHIC 26978
22 ex23-1_002.jpg GRAPHIC 14803
  Complete submission text file 0001493152-23-025645.txt   4944226
Mailing Address GROSSMATT 6, NW HERGISWIL V8 CH-6052
Business Address GROSSMATT 6, NW HERGISWIL V8 CH-6052 41786645430
BioLingus (Cayman) Ltd (Filer) CIK: 0001966522 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0430
Type: F-1/A | Act: 33 | File No.: 333-273093 | Film No.: 231116554
SIC: 2834 Pharmaceutical Preparations